BIO-RAD LABORATORIES, INC. 8-K

What Happened

• Bio‑Rad Laboratories, Inc. filed a Form 8‑K on April 30, 2026 announcing its financial results for the quarter ended March 31, 2026. The company furnished a press release reporting those results as Exhibit 99.1.
• The filing also incorporates by reference a Regulation FD disclosure related to a Supplemental Earnings Presentation (Exhibit 99.2), both dated April 30, 2026. The cover page Inline XBRL tags were provided as Exhibit 104.1.

Key Details

• Filing date: April 30, 2026 (Form 8‑K).
• Reporting period: quarter ended March 31, 2026.
• Exhibits furnished: 99.1 — press release (Apr 30, 2026); 99.2 — Supplemental Earnings Presentation (Apr 30, 2026); 104.1 — Inline XBRL cover page.
• Item references: Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 9.01 (Exhibits).

Why It Matters

• The 8‑K notifies investors that Bio‑Rad has publicly released its quarterly financial results and supporting presentation; the detailed revenue, earnings, and any commentary on trends or guidance are contained in the furnished exhibits.
• The Regulation FD disclosure indicates this information was provided in a manner intended to be broadly available to investors; shareholders and analysts should review Exhibits 99.1 and 99.2 for the specific financial metrics and management commentary needed to assess the company’s recent performance.